anayamalik, Author at European Medical Journal - Page 95 of 96

New Pathways Discovered in Viral Lung Fibrosis

Researchers have uncovered a critical mechanism behind why certain viral infections, such as COVID-19, lead to lasting lung damage.

Endothelin Blockade: A New Hope for Post-COVID Arthritis

Emerging research has linked COVID-19 to joint pain and osteoarthritis, but the precise mechanisms behind this connection and the damage to articular cartilage were previously unclear.

Is Radiotherapy Safe for Patients with Systemic Sclerosis?

The effects of radiotherapy on patients with systemic sclerosis (SSc) who develop cancer is a subject of growing concern due to the potential exacerbation of SSc symptoms and the risks of radiotherapy-related toxicity.

The Truth About Stiff-Person Syndrome

Stiff-person syndrome is a rare and disabling autoimmune disorder that presents evolving diagnostic challenges for clinicians.

Students Struggle with Dermatology Education Lacking in Diversity

Gaps in dermatology education have been spotlighted in preclinical medical students.

ChatGPT Triumph Over Physicians In Pediatric Pulmonology

LARGE language models are commended for offering support and ease of workload in healthcare settings. A recent study demonstrated that ChatGPT significantly outperformed trainee doctors in diagnosing complex respiratory conditions in children.

Shared Care Decisions Boost Physician–Patient Trust: The TRUMP2-SLE Study

Patient participation in shared decision-making is said to be beneficial when it comes to disease management, yet, few studies have researched this in the management of systemic lupus erythematosus.

Artificial Light Exposure at Night Linked to Alzheimer’s Risk

Emerging research has discovered a potential link between exposure to outdoor nighttime light pollution and an increased prevalence of Alzheimer’s disease.

Surgery Refusal May Indicate High Suicide Risk in Cancer

A recent study by Stanford University School of Medicine, California, has uncovered a significant correlation between patients with cancer who do not opt for surgery and an elevated risk of suicide.

Mayo Clinic Gut Microbiome Tool Identifies Disease Relapse Or Recovery

The latest development in the rapidly advancing arena of microbiome research is in the form of an innovative computational tool, the Gut Microbiome Wellness Index 2 (GMWI2), which shows promise in enhancing predictive healthcare by analyzing gut health.